title: Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?
authors.affiliation: CESAV, Center for Health Economics, IRCCS Institute for Pharmacological Research 'Mario Negri', Via Camozzi 3, 24020, Ranica, Italy.
authors.forename: Katelijne
authors.initials: K
authors.lastname: van de Vooren
authors.forename: Alessandro
authors.initials: A
authors.lastname: Curto
authors.forename: Livio
authors.initials: L
authors.lastname: Garattini
mesh_terms: D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005060:Europe; D006291:Health Policy / Q000191:economics; D006526:Hepatitis C / Q000188:drug therapy / Q000191:economics*; D006801:Humans
chemical_list: D000998:Antiviral Agents